{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,27]],"date-time":"2026-08-27T01:58:50Z","timestamp":1787795930981,"version":"build-2784847793"},"reference-count":64,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,12,26]],"date-time":"2025-12-26T00:00:00Z","timestamp":1766707200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,12,26]],"date-time":"2025-12-26T00:00:00Z","timestamp":1766707200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82271475"],"award-info":[{"award-number":["82271475"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82201587"],"award-info":[{"award-number":["82201587"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Taishan Young Scholarship"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Neurobiol"],"published-print":{"date-parts":[[2026,1]]},"DOI":"10.1007\/s12035-025-05442-y","type":"journal-article","created":{"date-parts":[[2025,12,26]],"date-time":"2025-12-26T02:43:47Z","timestamp":1766717027000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Proteins Associated with Cognition in Amyloid-beta Positive Elders Based on Cerebrospinal Fluid Proteomics"],"prefix":"10.1007","volume":"63","author":[{"given":"Min","family":"Liu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"He-Ying","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yan","family":"Fu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hao-Chen","family":"Chi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liang-Yu","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lan","family":"Tan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hao","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,12,26]]},"reference":[{"key":"5442_CR1","doi-asserted-by":"publisher","first-page":"1577","DOI":"10.1016\/s0140-6736(20)32205-4","volume":"397","author":"P Scheltens","year":"2021","unstructured":"Scheltens P, De Strooper B, Kivipelto M et al (2021) Alzheimer\u2019s disease. Lancet 397:1577\u20131590. https:\/\/doi.org\/10.1016\/s0140-6736(20)32205-4","journal-title":"Lancet"},{"key":"5442_CR2","doi-asserted-by":"publisher","unstructured":"(2023) 2023 Alzheimer's disease facts and figures. Alzheimers Dement 19:1598\u2013695. https:\/\/doi.org\/10.1002\/alz.13016","DOI":"10.1002\/alz.13016"},{"key":"5442_CR3","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1186\/s13024-021-00474-z","volume":"16","author":"B Bai","year":"2021","unstructured":"Bai B, Vanderwall D, Li Y et al (2021) Proteomic landscape of Alzheimer\u2019s disease: novel insights into pathogenesis and biomarker discovery. Mol Neurodegener 16:55. https:\/\/doi.org\/10.1186\/s13024-021-00474-z","journal-title":"Mol Neurodegener"},{"key":"5442_CR4","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1038\/s41583-019-0240-3","volume":"21","author":"R van der Kant","year":"2020","unstructured":"van der Kant R, Goldstein LSB, Ossenkoppele R (2020) Amyloid-\u03b2-independent regulators of tau pathology in Alzheimer disease. Nat Rev Neurosci 21:21\u201335. https:\/\/doi.org\/10.1038\/s41583-019-0240-3","journal-title":"Nat Rev Neurosci"},{"key":"5442_CR5","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1007\/s00401-014-1375-y","volume":"129","author":"DR Thal","year":"2015","unstructured":"Thal DR, Walter J, Saido TC et al (2015) Neuropathology and biochemistry of A\u03b2 and its aggregates in Alzheimer\u2019s disease. Acta Neuropathol 129:167\u2013182. https:\/\/doi.org\/10.1007\/s00401-014-1375-y","journal-title":"Acta Neuropathol"},{"key":"5442_CR6","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1186\/s40478-019-0795-2","volume":"7","author":"CD Whelan","year":"2019","unstructured":"Whelan CD, Mattsson N, Nagle MW et al (2019) Multiplex proteomics identifies novel CSF and plasma biomarkers of early Alzheimer\u2019s disease. Acta Neuropathol Commun 7:169. https:\/\/doi.org\/10.1186\/s40478-019-0795-2","journal-title":"Acta Neuropathol Commun"},{"key":"5442_CR7","doi-asserted-by":"publisher","DOI":"10.3390\/ijms241814225","author":"P Liu","year":"2023","unstructured":"Liu P, Li L, He F et al (2023) Identification of candidate biomarkers of Alzheimer\u2019s disease via multiplex cerebrospinal fluid and serum proteomics. Int J Mol Sci. https:\/\/doi.org\/10.3390\/ijms241814225","journal-title":"Int J Mol Sci"},{"key":"5442_CR8","doi-asserted-by":"publisher","first-page":"306","DOI":"10.1038\/s41573-022-00391-w","volume":"21","author":"E Karran","year":"2022","unstructured":"Karran E, De Strooper B (2022) The amyloid hypothesis in Alzheimer disease: new insights from new therapeutics. Nat Rev Drug Discov 21:306\u2013318. https:\/\/doi.org\/10.1038\/s41573-022-00391-w","journal-title":"Nat Rev Drug Discov"},{"key":"5442_CR9","doi-asserted-by":"publisher","first-page":"715","DOI":"10.1038\/s41582-023-00883-2","volume":"19","author":"EE Congdon","year":"2023","unstructured":"Congdon EE, Ji C, Tetlow AM et al (2023) Tau-targeting therapies for Alzheimer disease: current status and future directions. Nat Rev Neurol 19:715\u2013736. https:\/\/doi.org\/10.1038\/s41582-023-00883-2","journal-title":"Nat Rev Neurol"},{"key":"5442_CR10","doi-asserted-by":"publisher","first-page":"1214","DOI":"10.1038\/s41467-017-01150-x","volume":"8","author":"S Palmqvist","year":"2017","unstructured":"Palmqvist S, Sch\u00f6ll M, Strandberg O et al (2017) Earliest accumulation of \u03b2-amyloid occurs within the default-mode network and concurrently affects brain connectivity. Nat Commun 8:1214. https:\/\/doi.org\/10.1038\/s41467-017-01150-x","journal-title":"Nat Commun"},{"key":"5442_CR11","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1016\/s1474-4422(12)70291-0","volume":"12","author":"CR Jack Jr","year":"2013","unstructured":"Jack CR Jr, Knopman DS, Jagust WJ et al (2013) Tracking pathophysiological processes in Alzheimer\u2019s disease: an updated hypothetical model of dynamic biomarkers. Lancet Neurol 12:207\u2013216. https:\/\/doi.org\/10.1016\/s1474-4422(12)70291-0","journal-title":"Lancet Neurol"},{"key":"5442_CR12","doi-asserted-by":"publisher","first-page":"378","DOI":"10.1001\/archneur.61.3.378","volume":"61","author":"DA Bennett","year":"2004","unstructured":"Bennett DA, Schneider JA, Wilson RS et al (2004) Neurofibrillary tangles mediate the association of amyloid load with clinical Alzheimer disease and level of cognitive function. Arch Neurol 61:378\u2013384. https:\/\/doi.org\/10.1001\/archneur.61.3.378","journal-title":"Arch Neurol"},{"key":"5442_CR13","doi-asserted-by":"publisher","first-page":"535","DOI":"10.1016\/j.jalz.2018.02.018","volume":"14","author":"CR Jack Jr","year":"2018","unstructured":"Jack CR Jr, Bennett DA, Blennow K et al (2018) NIA-AA Research Framework: Toward a biological definition of Alzheimer\u2019s disease. Alzheimers Dement 14:535\u2013562. https:\/\/doi.org\/10.1016\/j.jalz.2018.02.018","journal-title":"Alzheimers Dement"},{"key":"5442_CR14","doi-asserted-by":"publisher","first-page":"795","DOI":"10.1056\/NEJMoa1202753","volume":"367","author":"RJ Bateman","year":"2012","unstructured":"Bateman RJ, Xiong C, Benzinger TL et al (2012) Clinical and biomarker changes in dominantly inherited Alzheimer\u2019s disease. N Engl J Med 367:795\u2013804. https:\/\/doi.org\/10.1056\/NEJMoa1202753","journal-title":"N Engl J Med"},{"key":"5442_CR15","doi-asserted-by":"publisher","first-page":"R645","DOI":"10.1016\/j.cub.2018.04.080","volume":"28","author":"GR Grontvedt","year":"2018","unstructured":"Grontvedt GR, Schroder TN, Sando SB et al (2018) Alzheimer\u2019s disease. Curr Biol 28:R645\u2013R649. https:\/\/doi.org\/10.1016\/j.cub.2018.04.080","journal-title":"Curr Biol"},{"key":"5442_CR16","doi-asserted-by":"publisher","first-page":"1302","DOI":"10.1038\/s41593-021-00886-6","volume":"24","author":"C Yang","year":"2021","unstructured":"Yang C, Farias FHG, Ibanez L et al (2021) Genomic atlas of the proteome from brain, CSF and plasma prioritizes proteins implicated in neurological disorders. Nat Neurosci 24:1302\u20131312. https:\/\/doi.org\/10.1038\/s41593-021-00886-6","journal-title":"Nat Neurosci"},{"key":"5442_CR17","doi-asserted-by":"publisher","first-page":"14248","DOI":"10.1038\/s41598-017-14755-5","volume":"7","author":"J Candia","year":"2017","unstructured":"Candia J, Cheung F, Kotliarov Y et al (2017) Assessment of variability in the SOMAscan assay. Sci Rep 7:14248. https:\/\/doi.org\/10.1038\/s41598-017-14755-5","journal-title":"Sci Rep"},{"key":"5442_CR18","doi-asserted-by":"publisher","first-page":"e1434","DOI":"10.1212\/wnl.0000000000207725","volume":"101","author":"K Tsukita","year":"2023","unstructured":"Tsukita K, Sakamaki-Tsukita H, Kaiser S et al (2023) High-throughput CSF proteomics and machine learning to identify proteomic signatures for Parkinson disease development and progression. Neurology 101:e1434\u2013e1447. https:\/\/doi.org\/10.1212\/wnl.0000000000207725","journal-title":"Neurology"},{"key":"5442_CR19","doi-asserted-by":"publisher","DOI":"10.1126\/scitranslmed.adg4122","volume":"15","author":"R Haque","year":"2023","unstructured":"Haque R, Watson CM, Liu J et al (2023) A protein panel in cerebrospinal fluid for diagnostic and predictive assessment of Alzheimer\u2019s disease. Sci Transl Med 15:eadg4122. https:\/\/doi.org\/10.1126\/scitranslmed.adg4122","journal-title":"Sci Transl Med"},{"key":"5442_CR20","doi-asserted-by":"publisher","first-page":"517","DOI":"10.1016\/j.jalz.2015.09.009","volume":"12","author":"T Bittner","year":"2016","unstructured":"Bittner T, Zetterberg H, Teunissen CE et al (2016) Technical performance of a novel, fully automated electrochemiluminescence immunoassay for the quantitation of \u03b2-amyloid (1\u201342) in human cerebrospinal fluid. Alzheimers Dement 12:517\u2013526. https:\/\/doi.org\/10.1016\/j.jalz.2015.09.009","journal-title":"Alzheimers Dement"},{"key":"5442_CR21","doi-asserted-by":"publisher","first-page":"508","DOI":"10.1001\/jamaneurol.2019.4749","volume":"77","author":"PF Meyer","year":"2020","unstructured":"Meyer PF, Pichet Binette A, Gonneaud J et al (2020) Characterization of Alzheimer disease biomarker discrepancies using cerebrospinal fluid phosphorylated tau and AV1451 positron emission tomography. JAMA Neurol 77:508\u2013516. https:\/\/doi.org\/10.1001\/jamaneurol.2019.4749","journal-title":"JAMA Neurol"},{"key":"5442_CR22","doi-asserted-by":"publisher","first-page":"1460","DOI":"10.1016\/j.jalz.2018.01.013","volume":"14","author":"SE Schindler","year":"2018","unstructured":"Schindler SE, Gray JD, Gordon BA et al (2018) Cerebrospinal fluid biomarkers measured by Elecsys assays compared to amyloid imaging. Alzheimers Dement 14:1460\u20131469. https:\/\/doi.org\/10.1016\/j.jalz.2018.01.013","journal-title":"Alzheimers Dement"},{"key":"5442_CR23","doi-asserted-by":"publisher","first-page":"2913","DOI":"10.1016\/j.neurobiolaging.2015.08.007","volume":"36","author":"M Araque Caballero","year":"2015","unstructured":"Araque Caballero M, Brendel M, Delker A et al (2015) Mapping 3-year changes in gray matter and metabolism in A\u03b2-positive nondemented subjects. Neurobiol Aging 36:2913\u20132924. https:\/\/doi.org\/10.1016\/j.neurobiolaging.2015.08.007","journal-title":"Neurobiol Aging"},{"key":"5442_CR24","doi-asserted-by":"publisher","first-page":"70","DOI":"10.2967\/jnumed.112.109009","volume":"54","author":"SM Landau","year":"2013","unstructured":"Landau SM, Breault C, Joshi AD et al (2013) Amyloid-\u03b2 imaging with Pittsburgh compound B and florbetapir: comparing radiotracers and quantification methods. J Nucl Med 54:70\u201377. https:\/\/doi.org\/10.2967\/jnumed.112.109009","journal-title":"J Nucl Med"},{"key":"5442_CR25","doi-asserted-by":"publisher","first-page":"1208","DOI":"10.1016\/j.jalz.2019.05.006","volume":"15","author":"JT Yu","year":"2019","unstructured":"Yu JT, Li JQ, Suckling J et al (2019) Frequency and longitudinal clinical outcomes of Alzheimer\u2019s AT(N) biomarker profiles: a longitudinal study. Alzheimers Dement 15:1208\u20131217. https:\/\/doi.org\/10.1016\/j.jalz.2019.05.006","journal-title":"Alzheimers Dement"},{"key":"5442_CR26","doi-asserted-by":"publisher","first-page":"819","DOI":"10.1016\/j.biopsych.2019.12.021","volume":"87","author":"JA Elman","year":"2020","unstructured":"Elman JA, Panizzon MS, Gustavson DE et al (2020) Amyloid-\u03b2 positivity predicts cognitive decline but cognition predicts progression to amyloid-\u03b2 positivity. Biol Psychiatry 87:819\u2013828. https:\/\/doi.org\/10.1016\/j.biopsych.2019.12.021","journal-title":"Biol Psychiatry"},{"key":"5442_CR27","doi-asserted-by":"publisher","first-page":"502","DOI":"10.1007\/s11682-012-9186-z","volume":"6","author":"PK Crane","year":"2012","unstructured":"Crane PK, Carle A, Gibbons LE et al (2012) Development and assessment of a composite score for memory in the Alzheimer\u2019s Disease Neuroimaging Initiative (ADNI). Brain Imaging Behav 6:502\u2013516. https:\/\/doi.org\/10.1007\/s11682-012-9186-z","journal-title":"Brain Imaging Behav"},{"key":"5442_CR28","doi-asserted-by":"publisher","first-page":"517","DOI":"10.1007\/s11682-012-9176-1","volume":"6","author":"LE Gibbons","year":"2012","unstructured":"Gibbons LE, Carle AC, Mackin RS et al (2012) A composite score for executive functioning, validated in Alzheimer\u2019s disease neuroimaging initiative (ADNI) participants with baseline mild cognitive impairment. Brain Imaging Behav 6:517\u2013527. https:\/\/doi.org\/10.1007\/s11682-012-9176-1","journal-title":"Brain Imaging Behav"},{"key":"5442_CR29","doi-asserted-by":"publisher","first-page":"821","DOI":"10.1007\/s00401-018-1932-x","volume":"136","author":"JL Molinuevo","year":"2018","unstructured":"Molinuevo JL, Ayton S, Batrla R et al (2018) Current state of Alzheimer\u2019s fluid biomarkers. Acta Neuropathol 136:821\u2013853. https:\/\/doi.org\/10.1007\/s00401-018-1932-x","journal-title":"Acta Neuropathol"},{"key":"5442_CR30","doi-asserted-by":"publisher","DOI":"10.1126\/sciadv.adk3674","volume":"10","author":"F Shue","year":"2024","unstructured":"Shue F, White LJ, Hendrix R et al (2024) CSF biomarkers of immune activation and Alzheimer\u2019s disease for predicting cognitive impairment risk in the elderly. Sci Adv 10:eadk3674. https:\/\/doi.org\/10.1126\/sciadv.adk3674","journal-title":"Sci Adv"},{"key":"5442_CR31","doi-asserted-by":"publisher","DOI":"10.1186\/s12014-020-09285-8","volume":"17","author":"M Zhou","year":"2020","unstructured":"Zhou M, Haque RU, Dammer EB et al (2020) Targeted mass spectrometry to quantify brain-derived cerebrospinal fluid biomarkers in Alzheimer\u2019s disease. Clin Proteomics 17:19. https:\/\/doi.org\/10.1186\/s12014-020-09285-8","journal-title":"Clin Proteomics"},{"key":"5442_CR32","doi-asserted-by":"publisher","first-page":"665","DOI":"10.3233\/jad-2011-110566","volume":"27","author":"M Bjerke","year":"2011","unstructured":"Bjerke M, Zetterberg H, Edman \u00c5 et al (2011) Cerebrospinal fluid matrix metalloproteinases and tissue inhibitor of metalloproteinases in combination with subcortical and cortical biomarkers in vascular dementia and Alzheimer\u2019s disease. J Alzheimers Dis 27:665\u2013676. https:\/\/doi.org\/10.3233\/jad-2011-110566","journal-title":"J Alzheimers Dis"},{"key":"5442_CR33","doi-asserted-by":"publisher","first-page":"2259","DOI":"10.1046\/j.1471-4159.1994.63062259.x","volume":"63","author":"H Martin","year":"1994","unstructured":"Martin H, Rostas J, Patel Y et al (1994) Subcellular localisation of 14\u20133-3 isoforms in rat brain using specific antibodies. J Neurochem 63:2259\u20132265. https:\/\/doi.org\/10.1046\/j.1471-4159.1994.63062259.x","journal-title":"J Neurochem"},{"key":"5442_CR34","doi-asserted-by":"publisher","first-page":"387","DOI":"10.1042\/bst0300387","volume":"30","author":"HC Baxter","year":"2002","unstructured":"Baxter HC, Fraser JR, Liu WG et al (2002) Specific 14\u20133-3 isoform detection and immunolocalization in prion diseases. Biochem Soc Trans 30:387\u2013391. https:\/\/doi.org\/10.1042\/bst0300387","journal-title":"Biochem Soc Trans"},{"key":"5442_CR35","doi-asserted-by":"publisher","first-page":"2220","DOI":"10.7150\/ijbs.66604","volume":"18","author":"H Park","year":"2022","unstructured":"Park H, Lee YB, Chang KA (2022) Mir-200c suppression increases tau hyperphosphorylation by targeting 14\u20133-3\u03b3 in early stage of 5xFAD mouse model of Alzheimer\u2019s disease. Int J Biol Sci 18:2220\u20132234. https:\/\/doi.org\/10.7150\/ijbs.66604","journal-title":"Int J Biol Sci"},{"key":"5442_CR36","doi-asserted-by":"publisher","first-page":"4133","DOI":"10.1096\/fj.14-265009","volume":"29","author":"Y Joo","year":"2015","unstructured":"Joo Y, Schumacher B, Landrieu I et al (2015) Involvement of 14\u20133-3 in tubulin instability and impaired axon development is mediated by tau. FASEB j 29:4133\u20134144. https:\/\/doi.org\/10.1096\/fj.14-265009","journal-title":"FASEB j"},{"key":"5442_CR37","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1016\/j.neulet.2003.12.049","volume":"357","author":"F Hern\u00e1ndez","year":"2004","unstructured":"Hern\u00e1ndez F, Cuadros R, Avila J (2004) Zeta 14\u20133-3 protein favours the formation of human tau fibrillar polymers. Neurosci Lett 357:143\u2013146. https:\/\/doi.org\/10.1016\/j.neulet.2003.12.049","journal-title":"Neurosci Lett"},{"key":"5442_CR38","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1111\/j.1471-4159.2008.05716.x","volume":"108","author":"G Sadik","year":"2009","unstructured":"Sadik G, Tanaka T, Kato K et al (2009) Phosphorylation of tau at Ser214 mediates its interaction with 14\u20133-3 protein: implications for the mechanism of tau aggregation. J Neurochem 108:33\u201343. https:\/\/doi.org\/10.1111\/j.1471-4159.2008.05716.x","journal-title":"J Neurochem"},{"key":"5442_CR39","doi-asserted-by":"publisher","first-page":"226","DOI":"10.1016\/j.tips.2021.01.001","volume":"42","author":"FS Pair","year":"2021","unstructured":"Pair FS, Yacoubian TA (2021) 14\u20133-3 proteins: novel pharmacological targets in neurodegenerative diseases. Trends Pharmacol Sci 42:226\u2013238. https:\/\/doi.org\/10.1016\/j.tips.2021.01.001","journal-title":"Trends Pharmacol Sci"},{"key":"5442_CR40","doi-asserted-by":"publisher","first-page":"2590","DOI":"10.1016\/j.neuron.2021.06.005","volume":"109","author":"DS Roy","year":"2021","unstructured":"Roy DS, Zhang Y, Aida T et al (2021) Anterior thalamic dysfunction underlies cognitive deficits in a subset of neuropsychiatric disease models. Neuron 109:2590\u2013603.e13. https:\/\/doi.org\/10.1016\/j.neuron.2021.06.005","journal-title":"Neuron"},{"key":"5442_CR41","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1186\/s13024-023-00638-z","volume":"18","author":"ES Modeste","year":"2023","unstructured":"Modeste ES, Ping L, Watson CM et al (2023) Quantitative proteomics of cerebrospinal fluid from African Americans and Caucasians reveals shared and divergent changes in Alzheimer\u2019s disease. Mol Neurodegener 18:48. https:\/\/doi.org\/10.1186\/s13024-023-00638-z","journal-title":"Mol Neurodegener"},{"key":"5442_CR42","doi-asserted-by":"publisher","first-page":"463","DOI":"10.1146\/annurev.cellbio.17.1.463","volume":"17","author":"MD Sternlicht","year":"2001","unstructured":"Sternlicht MD, Werb Z (2001) How matrix metalloproteinases regulate cell behavior. Annu Rev Cell Dev Biol 17:463\u2013516. https:\/\/doi.org\/10.1146\/annurev.cellbio.17.1.463","journal-title":"Annu Rev Cell Dev Biol"},{"key":"5442_CR43","doi-asserted-by":"publisher","first-page":"3207","DOI":"10.1007\/s00018-019-03180-8","volume":"76","author":"A Beroun","year":"2019","unstructured":"Beroun A, Mitra S, Michaluk P et al (2019) MMPs in learning and memory and neuropsychiatric disorders. Cell Mol Life Sci 76:3207\u20133228. https:\/\/doi.org\/10.1007\/s00018-019-03180-8","journal-title":"Cell Mol Life Sci"},{"key":"5442_CR44","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1016\/s1474-4422(09)70016-x","volume":"8","author":"GA Rosenberg","year":"2009","unstructured":"Rosenberg GA (2009) Matrix metalloproteinases and their multiple roles in neurodegenerative diseases. Lancet Neurol 8:205\u2013216. https:\/\/doi.org\/10.1016\/s1474-4422(09)70016-x","journal-title":"Lancet Neurol"},{"key":"5442_CR45","doi-asserted-by":"publisher","first-page":"10939","DOI":"10.1523\/jneurosci.2085-06.2006","volume":"26","author":"KJ Yin","year":"2006","unstructured":"Yin KJ, Cirrito JR, Yan P et al (2006) Matrix metalloproteinases expressed by astrocytes mediate extracellular amyloid-beta peptide catabolism. J Neurosci 26:10939\u201310948. https:\/\/doi.org\/10.1523\/jneurosci.2085-06.2006","journal-title":"J Neurosci"},{"key":"5442_CR46","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0018850","volume":"6","author":"R Craig-Schapiro","year":"2011","unstructured":"Craig-Schapiro R, Kuhn M, Xiong C et al (2011) Multiplexed immunoassay panel identifies novel CSF biomarkers for Alzheimer\u2019s disease diagnosis and prognosis. PLoS ONE 6:e18850. https:\/\/doi.org\/10.1371\/journal.pone.0018850","journal-title":"PLoS ONE"},{"key":"5442_CR47","doi-asserted-by":"publisher","first-page":"2507","DOI":"10.1093\/brain\/awac024","volume":"145","author":"PV Martino Adami","year":"2022","unstructured":"Martino Adami PV, Orellana A, Garc\u00eda P et al (2022) Matrix metalloproteinase 10 is linked to the risk of progression to dementia of the Alzheimer\u2019s type. Brain 145:2507\u20132517. https:\/\/doi.org\/10.1093\/brain\/awac024","journal-title":"Brain"},{"key":"5442_CR48","doi-asserted-by":"publisher","first-page":"17625","DOI":"10.1038\/s41598-017-17762-8","volume":"7","author":"E Pchitskaya","year":"2017","unstructured":"Pchitskaya E, Kraskovskaya N, Chernyuk D et al (2017) Stim2-eb3 association and morphology of dendritic spines in hippocampal neurons. Sci Rep 7:17625. https:\/\/doi.org\/10.1038\/s41598-017-17762-8","journal-title":"Sci Rep"},{"key":"5442_CR49","doi-asserted-by":"publisher","DOI":"10.3390\/ijms23042274","author":"E Pchitskaya","year":"2022","unstructured":"Pchitskaya E, Rakovskaya A, Chigray M et al (2022) Cytoskeleton protein EB3 contributes to dendritic spines enlargement and enhances their resilience to toxic effects of beta-amyloid. Int J Mol Sci. https:\/\/doi.org\/10.3390\/ijms23042274","journal-title":"Int J Mol Sci"},{"key":"5442_CR50","doi-asserted-by":"publisher","first-page":"381","DOI":"10.1016\/j.conb.2007.04.009","volume":"17","author":"J Bourne","year":"2007","unstructured":"Bourne J, Harris KM (2007) Do thin spines learn to be mushroom spines that remember? Curr Opin Neurobiol 17:381\u2013386. https:\/\/doi.org\/10.1016\/j.conb.2007.04.009","journal-title":"Curr Opin Neurobiol"},{"key":"5442_CR51","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1016\/j.neuron.2008.11.013","volume":"61","author":"J Jaworski","year":"2009","unstructured":"Jaworski J, Kapitein LC, Gouveia SM et al (2009) Dynamic microtubules regulate dendritic spine morphology and synaptic plasticity. Neuron 61:85\u2013100. https:\/\/doi.org\/10.1016\/j.neuron.2008.11.013","journal-title":"Neuron"},{"key":"5442_CR52","doi-asserted-by":"publisher","first-page":"6550","DOI":"10.1038\/s41380-021-01143-9","volume":"26","author":"A Hadar","year":"2021","unstructured":"Hadar A, Kapitansky O, Ganaiem M et al (2021) Introducing ADNP and SIRT1 as new partners regulating microtubules and histone methylation. Mol Psychiatry 26:6550\u20136561. https:\/\/doi.org\/10.1038\/s41380-021-01143-9","journal-title":"Mol Psychiatry"},{"key":"5442_CR53","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0210864","volume":"14","author":"CL Sayas","year":"2019","unstructured":"Sayas CL, Medina M, Cuadros R et al (2019) Role of tau N-terminal motif in the secretion of human tau by end binding proteins. PLoS ONE 14:e0210864. https:\/\/doi.org\/10.1371\/journal.pone.0210864","journal-title":"PLoS ONE"},{"key":"5442_CR54","doi-asserted-by":"publisher","first-page":"182","DOI":"10.1093\/jnen\/nlab134","volume":"81","author":"A Anad","year":"2022","unstructured":"Anad A, Barker MK, Katanga JA et al (2022) Vasculocentric axonal NfH in small vessel disease. J Neuropathol Exp Neurol 81:182\u2013192. https:\/\/doi.org\/10.1093\/jnen\/nlab134","journal-title":"J Neuropathol Exp Neurol"},{"key":"5442_CR55","doi-asserted-by":"publisher","DOI":"10.3389\/fnins.2021.689938","volume":"15","author":"A Yuan","year":"2021","unstructured":"Yuan A, Nixon RA (2021) Neurofilament proteins as biomarkers to monitor neurological diseases and the efficacy of therapies. Front Neurosci 15:689938. https:\/\/doi.org\/10.3389\/fnins.2021.689938","journal-title":"Front Neurosci"},{"key":"5442_CR56","doi-asserted-by":"publisher","first-page":"4560","DOI":"10.2174\/1381612825666191210154535","volume":"25","author":"Y Lee","year":"2020","unstructured":"Lee Y, Lee BH, Yip W et al (2020) Neurofilament proteins as prognostic biomarkers in neurological disorders. Curr Pharm Des 25:4560\u20134569. https:\/\/doi.org\/10.2174\/1381612825666191210154535","journal-title":"Curr Pharm Des"},{"key":"5442_CR57","doi-asserted-by":"publisher","first-page":"1297","DOI":"10.1007\/s00415-023-12066-6","volume":"271","author":"A Vrillon","year":"2024","unstructured":"Vrillon A, Ashton NJ, Karikari TK et al (2024) Comparison of CSF and plasma NfL and pNfH for Alzheimer\u2019s disease diagnosis: a memory clinic study. J Neurol 271:1297\u20131310. https:\/\/doi.org\/10.1007\/s00415-023-12066-6","journal-title":"J Neurol"},{"key":"5442_CR58","doi-asserted-by":"publisher","first-page":"1979","DOI":"10.1038\/s41591-023-02476-4","volume":"29","author":"ECB Johnson","year":"2023","unstructured":"Johnson ECB, Bian S, Haque RU et al (2023) Cerebrospinal fluid proteomics define the natural history of autosomal dominant Alzheimer\u2019s disease. Nat Med 29:1979\u20131988. https:\/\/doi.org\/10.1038\/s41591-023-02476-4","journal-title":"Nat Med"},{"key":"5442_CR59","doi-asserted-by":"publisher","first-page":"3756","DOI":"10.1093\/brain\/awab335","volume":"144","author":"M Reinartz","year":"2021","unstructured":"Reinartz M, Gabel S, Schaeverbeke J et al (2021) Changes in the language system as amyloid-\u03b2 accumulates. Brain 144:3756\u20133768. https:\/\/doi.org\/10.1093\/brain\/awab335","journal-title":"Brain"},{"key":"5442_CR60","doi-asserted-by":"publisher","first-page":"1539","DOI":"10.3233\/jad-160252","volume":"54","author":"KD Mueller","year":"2016","unstructured":"Mueller KD, Koscik RL, Turkstra LS et al (2016) Connected language in late middle-aged adults at risk for Alzheimer\u2019s disease. J Alzheimers Dis 54:1539\u20131550. https:\/\/doi.org\/10.3233\/jad-160252","journal-title":"J Alzheimers Dis"},{"key":"5442_CR61","doi-asserted-by":"publisher","first-page":"595","DOI":"10.15252\/emmm.201606210","volume":"8","author":"DJ Selkoe","year":"2016","unstructured":"Selkoe DJ, Hardy J (2016) The amyloid hypothesis of Alzheimer\u2019s disease at 25 years. EMBO Mol Med 8:595\u2013608. https:\/\/doi.org\/10.15252\/emmm.201606210","journal-title":"EMBO Mol Med"},{"key":"5442_CR62","doi-asserted-by":"publisher","first-page":"354","DOI":"10.1007\/s12035-021-02611-7","volume":"59","author":"M Kumar","year":"2022","unstructured":"Kumar M, Bansal N (2022) Implications of phosphoinositide 3-kinase-Akt (PI3K-Akt) pathway in the pathogenesis of Alzheimer\u2019s disease. Mol Neurobiol 59:354\u2013385. https:\/\/doi.org\/10.1007\/s12035-021-02611-7","journal-title":"Mol Neurobiol"},{"key":"5442_CR63","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1016\/j.neurobiolaging.2023.09.015","volume":"134","author":"M Zhu","year":"2024","unstructured":"Zhu M, Gu H, Bai H et al (2024) Role and molecular regulatory mechanisms of Hippo signaling pathway in Caenorhabditis elegans and mammalian cell models of Alzheimer\u2019s disease. Neurobiol Aging 134:9\u201320. https:\/\/doi.org\/10.1016\/j.neurobiolaging.2023.09.015","journal-title":"Neurobiol Aging"},{"key":"5442_CR64","doi-asserted-by":"publisher","first-page":"e12179","DOI":"10.1002\/dad2.12179","volume":"13","author":"J Nilsson","year":"2021","unstructured":"Nilsson J, Gobom J, Sj\u00f6din S et al (2021) Cerebrospinal fluid biomarker panel for synaptic dysfunction in Alzheimer\u2019s disease. Alzheimers Dement (Amst) 13:e12179. https:\/\/doi.org\/10.1002\/dad2.12179","journal-title":"Alzheimers Dement (Amst)"}],"container-title":["Molecular Neurobiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12035-025-05442-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12035-025-05442-y","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12035-025-05442-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,26]],"date-time":"2025-12-26T02:43:49Z","timestamp":1766717029000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12035-025-05442-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12,26]]},"references-count":64,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026,1]]}},"alternative-id":["5442"],"URL":"https:\/\/doi.org\/10.1007\/s12035-025-05442-y","relation":{},"ISSN":["0893-7648","1559-1182"],"issn-type":[{"value":"0893-7648","type":"print"},{"value":"1559-1182","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,12,26]]},"assertion":[{"value":"8 October 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 August 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 December 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study procedures were approved by the institutional review boards of all participating centres (\n                      \n                      ), and written informed consent was obtained from all participants or their authorised representatives according to the Declaration of Helsinki (consent for research). Ethics approval was obtained from the institutional review boards of each institution involved: Oregon Health and Science University; University of Southern California; University of California\u2014San Diego; University of Michigan; Mayo Clinic, Rochester; Baylor College of Medicine; Columbia University Medical Center; Washington University, St. Louis; University of Alabama at Birmingham; Mount Sinai School of Medicine; Rush University Medical Center; Wien Center; Johns Hopkins University; New York University; Duke University Medical Center; University of Pennsylvania; University of Kentucky; University of Pittsburgh; University of Rochester Medical Center; University of California, Irvine; University of Texas Southwestern Medical School; Emory University; University of Kansas, Medical Center; University of California, Los Angeles; Mayo Clinic, Jacksonville; Indiana University; Yale University School of Medicine; McGill University, Montreal-Jewish General Hospital; Sunnybrook Health Sciences, Ontario; U.B.C. Clinic for AD & Related Disorders; Cognitive Neurology\u2014St. Joseph\u2019s, Ontario; Cleveland Clinic Lou Ruvo Center for Brain Health; Northwestern University; Premiere Research Inst (Palm Beach Neurology); Georgetown University Medical Center; Brigham and Women\u2019s Hospital; Stanford University; Banner Sun Health Research Institute; Boston University; Howard University; Case Western Reserve University; University of California, Davis\u2014Sacramento; Neurological Care of CNY; Parkwood Hospital; University of Wisconsin; University of California, Irvine\u2014BIC; Banner Alzheimer\u2019s Institute; Dent Neurologic Institute; Ohio State University; Albany Medical College; Hartford Hospital, Olin Neuropsychiatry Research Center; Dartmouth-Hitchcock Medical Center; Wake Forest University Health Sciences; Rhode Island Hospital; Butler Hospital; UC San Francisco; Medical University South Carolina; St. Joseph\u2019s Health Care Nathan Kline Institute; University of Iowa College of Medicine; Cornell University and University of South Florida: USF Health Byrd Alzheimer\u2019s Institute. The investigators within the ADNI contributed to the design and implementation of the ADNI and\/or provided data but did not participate in analysis or writing of this report. A complete listing of ADNI investigators can be found online (\n                      \n                      ).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no conflict of interest.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"327"}}